The utility of peptide nucleic acid fluorescence in situ hybridization (PNA FISH) for the detection of Acinetobacter spp. and Pseudomonas aeruginosa was evaluated on broth suspensions and spiked blood cultures of ATCC strains and clinical isolates with select gram-negative rods. After testing 60 clinical isolates, PNA FISH had a sensitivity and specificity of 100% and 100%, respectively, for Acinetobacter spp. and 100% and 95%, respectively, for P. aeruginosa. PNA FISH was able to detect both pathogens simultaneously and directly from spiked blood cultures.
Pseudomonas aeruginosa and Acinetobacter baumannii have emerged as two of the most troublesome pathogens for health care institutions globally, contributing significantly to the morbidity and mortality of hospitalized patients (8, 9) . Novel, rapid diagnostics are urgently required to assist in the epidemiological control and early treatment of infection caused by these organisms (10) .
Fluorescence in situ hybridization (FISH) using labeled peptide nucleic acid (PNA) probes is a methodology that has been applied for the rapid diagnosis of infectious diseases (7, 11) . Due to their neutral charge, PNA probes have more-robust hybridization characteristics than those of DNA probes. They target naturally abundant rRNA molecules and, thus, allow the detection of individual microorganisms without the need for an amplification step (5) . Finally, and adding to its clinical applicability, PNA FISH is less susceptible to inhibition by impurities in clinical samples and has been used effectively for the direct testing of blood, sputum, and wound cultures (2, 6, 7) . Thus far, this technology has not been applied to A. baumannii and has only recently been described for P. aeruginosa (7) . In this study, we assessed the effectiveness of a new, genus-specific Acinetobacter sp. PNA probe (AdvanDx, Inc., Woburn, MA) by testing a range of reference and clinical isolates. Given the similarity of infectious syndromes caused by A. baumannii and P. aeruginosa, we also assessed the ability of using the Acinetobacter sp. and P. aeruginosa probes (AdvanDx, Inc., Woburn, MA) simultaneously. Currently, both probes are for research use only.
The PNA FISH assay was performed according to published methods (11, 12) . In brief, a 10-l aliquot from an overnight culture (grown in brain heart infusion agar at 37°C) was mixed with 1 drop of fixation solution on a slide. After fixation, 1 drop of the probe solution was placed on the slide and hybridized at 55°C for 90 min (12) . The slides were then washed for 30 min and were read using a fluorescence microscope with a dual fluorescein isothiocyanate/Texas Red filter. The final PNA FISH result was available in ϳ2.5 h. Two independent investigators, who were blinded to the laboratory identification of the samples, examined all slides.
Initially, a group of ATCC reference strains was assessed using the genus-specific Acinetobacter sp. . PNA FISH testing with the Acinetobacter sp. probe correctly identified all Acinetobacter ATCC reference strains and no cross-hybridization with other ATCC reference gram-negative organisms were observed. We also assessed, in a separate experiment, the same group of ATCC strains with the previously designed P. aeruginosa probe (7). The P. aeruginosa probe correctly identified P. aeruginosa ATCC 10145 and showed no cross-hybridization with other Pseudomonas species or with other ATCC reference gram-negative organisms.
Following this initial validation, the Acinetobacter sp. and P. aeruginosa PNA probes were combined and used simultaneously to test 60 recent clinical isolates. Each probe had a different fluorescent marker as follows: green (fluorescein isothiocyanate) for Acinetobacter spp. and red (Texas Red) for P. aeruginosa. The clinical isolates included 20 Acinetobacter sp. strains, 20 P. aeruginosa strains, and 20 other strains with gramnegative rods (Table 1 ). All isolates were obtained from different patients and were resistant to at least three antimicrobial groups. The Acinetobacter sp. and P. aeruginosa isolates were confirmed to be of different genetic types, as determined by pulsed-field gel electrophoresis, which was performed according to previously described methods (4) . Organism identification and susceptibility testing had been performed in a clinical microbiology laboratory according to CLSI standards (3) . Using the multiprobe PNA FISH assay on the 60 clinical isolates individually, the sensitivity and specificity for Acineto-bacter spp. were 100% and 100%, respectively, and for P. aeruginosa, they were 100% and 95%, respectively (Table 1) . Routine laboratory organism identification was used as the gold standard. The two false-positive results were from Stenotrophomonas maltophilia and Escherichia coli, which both produced a weak red signal identified as P. aeruginosa. After repeat testing, these results were negative. The positive and negative predictive values were 91% and 100%, respectively, for P. aeruginosa detection. There was no interobserver variability.
To determine the threshold of detection for the multiprobe PNA FISH assay, serial dilutions of an overnight culture of A. baumannii (ATCC 19606) and P. aeruginosa (ATCC 10145) were tested. The bacterial densities (CFU/ml) of the dilutions were confirmed by colony counts on brain heart infusion agar. We observed that the lower limit of detection for the multiprobe PNA FISH assay was 10 4 CFU/ml for both Acinetobacter spp. and P. aeruginosa. Given that hospital-acquired and ventilator-associated pneumonia is the most common infectious syndrome caused by these organisms, such a threshold is clinically applicable (1) .
To assess whether Acinetobacter spp. and P. aeruginosa could be identified simultaneously, 10 mixed bacterial broth cultures were prepared. Each mixed culture consisted of a random selection of 3 isolates from the 60 clinical isolates described above. Each mixed culture was prepared by combining 1 ml of an overnight culture of each isolate. All mixed cultures, which were tested in a blinded fashion, were correctly identified by using the multiprobe PNA FISH assay. A total of 6 of these 10 mixed cultures contained both Acinetobacter spp. and P. aeruginosa (Fig. 1A) .
Finally, to determine whether this multiprobe PNA FISH assay could be used directly on positive blood cultures, we prepared artificially spiked BacT/Alert SA blood culture bottles (bioMerieux, Inc., Durham, NC), which contained 10 ml of seeded human blood (Research Blood Components, Brighton, MA). One colony of A. baumannii (ATCC 19606) or P. aeruginosa (ATCC 10145) from a fresh agar plate was used to inoculate two bottles each, and they were incubated aerobically at 37°C for 3 to 6 h before testing. Two further bottles were also inoculated with the two organisms combined. We observed (ATCC 19606) and Pseudomonas aeruginosa (ATCC 10145) using PNA probes specific for these organisms. Green fluorescence signifies hybridization with Acinetobacter spp., and red signifies hybridization with P. aeruginosa. A sample from an overnight broth culture (A) and a sample from a spiked blood culture bottle taken 3 h after inoculation (B) are shown, presenting evidence of both microbes and overlying red cells. (Fig. 1B) . PNA FISH testing is a rapid and highly sensitive and specific method for the detection of troublesome gram-negative pathogens such as P. aeruginosa and Acinetobacter spp. Importantly, the methodology has the potential to be used on direct clinical samples, and we have demonstrated its potential for pathogen detection from blood cultures. The commonality of infection types caused by these organisms, particularly pneumonia and bloodstream infection, makes simultaneous detection clinically useful. Such rapid diagnostics have the potential to not only improve therapeutic decision making but may also help optimize infection control interventions by more rapidly identifying patient or environmental reservoirs. Before the full utility of this new technology can be determined, it is important for further clinical studies to be performed.
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